3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Stroke
1
Recurrence
1
Ovarian Neoplasms
1
Neurologic Manifestations
1
Melanoma
1
Margins of Excision
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Inflammatory Breast Neoplasms
1
Glioblastoma
1
Fallopian Tube Neoplasms
1
Communication
1
Colorectal Neoplasms
1
Caregiver Burden
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Brain Neoplasms
1
Brain Injuries, Traumatic
1
Brain Injuries
1
Advanced Malignant Solid Neoplasm
1
Interventions
Radiotherapy
5
Oxaliplatin
5
Nivolumab
5
Fluorouracil
5
Cetuximab
5
Leucovorin
4
Magnetic Resonance Spectroscopy
3
Bevacizumab
3
sintilimab
2
pembrolizumab
2
fludarabine
2
encorafenib
2
aldesleukin
2
Tomography, X-Ray Computed
2
Specimen Handling
2
Pemetrexed
2
Magnetic Resonance Imaging
2
Irinotecan
2
Gemcitabine
2
Folfox protocol
2
Electrocardiography
2
Drug Therapy
2
Dexamethasone
2
Cyclophosphamide
2
Cisplatin
2
Carboplatin
2
Biopsy
2
ulixertinib
1
trifluridine tipiracil drug combination
1
trastuzumab biosimilar HLX02
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Palliative Care
×
30 days
×
Clear all
No trials found.